We now have a complementary study that helps extend the picture. If the first paper suggests post-COVID biology may exist on a spectrum, this second one suggests recovery itself may also be real, prolonged, and only partial.🧵
This was a 2 year longitudinal proteomics study of hospitalized COVID survivors. The researchers profiled plasma at 6 months, 1 year, and 2 years after symptom onset and compared it with matched healthy controls.
This cohort was infected in the very early 2020 wave.
The encouraging part is that recovery clearly does happen. The number of differentially expressed proteins fell over time, from 172 at 6 months to 109 at 1 year and 73 at 2 years.
But recovery was not complete, and it was not synchronized. Different pathways normalized on different timelines, which is exactly what you would expect in a layered post infectious condition rather than a simple on/off state.
Some pathways, including focal adhesion, extracellular matrix-receptor interaction, and actin cytoskeleton regulation, improved between 6 months and 1 year.
Other systems appeared to recover more slowly. Cholesterol metabolism shifted closer to control levels between 1 and 2 years, while most immune response pathways - including complement and coagulation - also moved toward, though not necessarily fully back to, control levels before the 2-year mark.
But the reassuring reading would be a mistake. This was not a clean return to baseline. Even after 2 years, some neuron-related signaling pathways remained suppressed, and some oxidative stress-related proteins were still persistently altered. The biology was still carrying damage forward.
And even where parts of the proteomic immune signal moved closer to controls, that should not be mistaken for full recovery. What this study shows is uneven, partial recovery at best - not a complete reset.
That matters because it pushes back against two comforting myths at once. Not only the idea that people either have or don’t have long COVID, but also the idea that recovery is naturally rapid, uniform, or complete.
The picture here is not one of restoration. It is one of prolonged biological disruption, with some systems improving, others lagging, and some still measurably abnormal years later.
And this broader pattern is not without precedent. We have seen in other infections - especially HIV - that biological recovery can remain incomplete long after the acute phase, with persistent effects in immune signaling, oxidative stress, and neuroinflammatory pathways.
It does mean the basic idea is not exotic. An infection can end clinically, while parts of the biology remain dysregulated for much longer.
That is why post-COVID illness may be better understood not as a simple yes/no condition, but as a prolonged and uneven process of partial recovery.
And if 40 years of HIV research still haven’t answered every post-infectious question, the lesson should be obvious. Take non-pharmaceutical prevention seriously and avoid reinfections. Prevention matters far more than people want to admit.
Gu at al., Probing long COVID through a proteomic lens: a comprehensive two-year longitudinal cohort study of hospitalised survivors. thelancet.com/journals/ebiom…
• • •
Missing some Tweet in this thread? You can try to
force a refresh
COVID-19 creates a state of immune dysregulation where the body may lose control over things it normally keeps suppressed - latent viruses, especially herpesviruses, and possibly even dormant cancer cells.
A new study on EBV and CD8 T cells fits into this bigger picture.🧵
The point is not simply that EBV can reactivate during COVID. We already have quite a lot of evidence for that.
In hospitalized patients with acute COVID, EBV reactivation was very common - around 68-73% - and it was seen not only in critical cases, but also in moderate disease.
The authors looked at EBV, CMV, HHV-6A and HHV-6B.
EBV dominated.
CMV and HHV-6B were detected only at low frequencies.
HHV-6A was not detected at all.
So this does not look like just random viral noise. EBV stands out.
Mental health problems have risen since the pandemic. And the evidence keeps growing that the main part of that burden may be a biological consequence of infection itself 🧵
A new preliminary study in older adults adds to that picture.
Researchers studied 24 adults aged 60+.
12 with persistent cognitive symptoms lasting more than 6 months, and 12 healthy age matched controls.
The Long COVID group showed significantly higher levels of depression and fatigue than the healthy controls.
One breast cancer study looked at 372 patients with early triple-negative breast cancer treated before surgery with pembrolizumab plus chemotherapy. Overall, 61.3% had a pathologic complete response.
But patients who started treatment with signs of a weaker immune profile did worse. When the neutrophil-to-lymphocyte ratio (NLR) was above 5, complete response rates were lower 45.7% vs 62.9%.
A useful Germany-based study looked at what happened after seasonal COVID vaccination moved into routine care. It used real-world insurance data to compare vaccinated and unvaccinated adults during the 2023/24 autumn-winter period🧵
The main pattern was consistent. Vaccinated people had fewer severe outcomes. COVID-related hospitalization was lower. Respiratory and cardiovascular hospitalizations were also lower. New long COVID diagnoses were lower too.
The follow-up period ran for up to 121 days, essentially covering 1 December 2023 to 31 March 2024. So the paper is really about short-term seasonal impact, not long-term durability over many more months.
A new Scientific Reports study adds an important nuance to the long COVID conversation. The biggest difference was not between people with PCC and without PCC, but between uninfected people and everyone who had recovered from SARS2🧵
Long COVID may be part of a broader post-infectious biological spectrum, where symptomatic PCC represents the more clinically visible end of a continuous dysregulation rather than a completely separate category.
That matters, because a lot of people still think in very rigid categories here. But instead of two clean boxes - recovered vs long COVID - the biology may look more like a continuum.
A new study asks a deceptively simple question - is Long COVID just a slower recovery, or is it a persistent immune disorder? Their data point toward the latter !🧵
For this single-cell analysis, the authors selected 9 women from a prospective cohort of patients hospitalized with COVID-19. Blood was collected during acute infection, at 3 months, and again 18-24 months later. Some recovered without long-term complications. Others developed pulmonary or cardiovascular Long COVID.
What makes the paper valuable is not the size of the cohort, but the depth of follow up. The authors profiled peripheral blood mononuclear cells at single-cell resolution and tracked how immune states evolved over time.